ArticleFrontiers in neurology2026
Adult Epstein-Barr virus encephalitis: a retrospective case report series with metagenomic next-generation sequencing-based diagnosis.
Article in Frontiers in neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: EBV encephalitis is uncommon in adults, and its diagnosis and management remain challenging, particularly in patients with underlying medical conditions. Methods: We retrospectively analyzed seven adult patients with EBV encephalitis confirmed through cerebrospinal fluid (CSF) metagenomic next-generation sequencing (mNGS) between December 2021 and January 2024. Results: Six patients (86%) were female, with a median age of 59 years. Five patients had significant underlying conditions, including malignancies ( Conclusion: MRI is the preferred imaging modality for suspected encephalitis, and CSF-mNGS is an essential pathogen detection assay. Underlying conditions such as malignancies and HLH are associated with poor clinical outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.